LabCentral

company

About

LabCentral developing novel cancer treatments: Conkwest, Inc, headquartered in DelMar, California, is opening its research laboratory at

  • Hardwick,Massachusetts,United States
  • 11 - 50

Details

Last Funding Type
Grant
Last Funding Money Raised
$249.62K
Industries
Education,Health Diagnostics,Medical
Founded date
Jan 1, 2012
Number Of Employee
11 - 50
Operating Status
Active

LabCentral developing novel cancer treatments: Conkwest, Inc, headquartered in DelMar, California, is opening its research laboratory at LabCentral. Conkwest is an innovative life sciences company that is developing and commercializing cell based treatments for cancer and viral infections.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
$13.24M
LabCentral has raised a total of $13.24M in funding over 2 rounds. Their latest funding was raised on Jan 27, 2022 from a Grant round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jan 27, 2022 Grant $249.62K 1 US Department of Commerce, Economic Development Administation Detail
Oct 6, 2019 Corporate Round $13M 2 Astellas Pharma Detail

Investors

Number of Lead Investors
Number of Investors
2
3
LabCentral is funded by 3 investors. US Department of Commerce, Economic Development Administation and Astellas Pharma are the most recent investors.
Investor Name Lead Investor Funding Round
US Department of Commerce, Economic Development Administation Yes Grant
Astellas Pharma Yes Corporate Round
MRL Ventures Fund Corporate Round

Employee Profiles

Number of Employee Profiles
6
LabCentral has 6 current employee profiles, including Executive Johannes Fruehauf
Executive
Board member
Executive
Executive
Employee